CGEM

Cullinan Oncology Inc

• TipRanks·31m ago

  Cullinan’s CLN-978 RA Trial: Early-Stage Catalyst in a Crowded Autoimmune Market

• TipRanks·7h ago

  Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cullinan Management (CGEM) and BeOne Medicines (ONC)

• Dow Jones·1d ago

  Cullinan Therapeutics Price Target Maintained With a $40.00/Share by BTIG

• Benzinga·1d ago

  BTIG Reiterates Buy on Cullinan Therapeutics, Maintains $40 Price Target

• TipRanks·1d ago

  Cullinan: Zipalertinib demonstrates ‘clinically meaningful’ antitumor activity

• Benzinga·1d ago

  Taiho Oncology and Cullinan Therapeutics Say Data From Cohort C Of Phase 2 REZILIENT2 Trial Of Zipalertinib For Locally Advanced Or Metastatic Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Or Uncommon EGFR Mutations and Active CNS Metastases Shows Intracranial Objective Response Rate Of 30.2% In 43 Evaluable Patients

• NASDAQ·10/08 13:43

  Cullinan Moves CLN-049 Into Phase 2 Development For Relapsed/Refractory AML

• TipRanks·10/08 11:20

  Cullinan Therapeutics doses first patient in CLN-049 trial

• Simply Wall St·10/08 01:33

  How FDA Filing Progress Will Impact Cullinan Therapeutics Stock

• TipRanks·10/07 14:55

  Cullinan Management (CGEM) Gets a Buy from Wedbush

• TipRanks·10/07 09:40

  Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Cullinan Management (CGEM)

• Simply Wall St·10/06 17:25

  Cullinan Therapeutics (CGEM) Starts Zipalertinib NDA Submission, Is The Stock Still 52% Undervalued?

• TipRanks·10/02 14:00

  Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)

• TipRanks·10/02 11:20

  Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Cullinan Management (CGEM)

• Dow Jones·10/02 10:42

  Cullinan Therapeutics Price Target Maintained With a $35.00/Share by HC Wainwright & Co.